**Core Concept**
Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that originates in the nasopharynx, and its treatment depends on the stage and severity of the disease. For early-stage NPCs like T1, the goal is to achieve local control and preserve surrounding structures.

**Why the Correct Answer is Right**
For T1 nasopharyngeal carcinoma, the recommended treatment is radiation therapy, specifically intensity-modulated radiation therapy (IMRT). This is because NPC is highly radiosensitive, and radiation can effectively target and eliminate cancer cells in the nasopharynx without causing excessive damage to surrounding tissues. IMRT further enhances the precision of radiation delivery, allowing for conformal radiation dosing and reduced toxicity.

**Why Each Wrong Option is Incorrect**
**Option A:** Surgery is not the primary treatment for T1 NPC due to the complex anatomy of the nasopharynx and the risk of significant morbidity. Although surgery may be considered in certain cases, it is generally reserved for salvage therapy after radiation failure.
**Option B:** Chemotherapy alone is not sufficient for T1 NPC, as it may not provide adequate local control. However, chemotherapy may be used in conjunction with radiation (chemoradiation) for more advanced stages of NPC.
**Option C:** Brachytherapy is a type of internal radiation therapy that involves placing radioactive material directly into or near the tumor. While brachytherapy can be effective for certain types of head and neck cancer, it is not the standard treatment for T1 NPC.

**Clinical Pearl / High-Yield Fact**
For NPC, the radiation dose and treatment volume are critical factors in determining treatment outcomes. A higher radiation dose may be required for more advanced stages of the disease, but this increases the risk of treatment-related toxicity.

**Correct Answer:** A. Radiation therapy (specifically IMRT) is the recommended treatment for T1 nasopharyngeal carcinoma.